Taiwan’s drug registration process, overseen by the Taiwan Food and Drug Administration (TFDA), involves multiple stages: pre-clinical testing, clinical trials, application submission, review, and approval. The process ensures drug safety, efficacy, and quality. Special pathways also exist for priority or orphan drugs to expedite their market entry.
